Ashutosh Mishra

Ashutosh Mishra

Auto-generated profile, based on publicly available information

Ashutosh Mishra

Department of Surgical Oncology Dr. B. R. Ambedkar Institute Rotary Cancer Hospital (IRCH) All India Institute of Medical Sciences New Delhi India

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 January 2020 in Journal of the Egyptian National Cancer Institute
Verified
Journal Article
Open access
PDF file
NKNavin Kumar
Navin Kumar
MRMukur Dipi Ray
Mukur Dipi Ray
DSD. N. Sharma
D. N. Sharma
RPRambha Pandey
Rambha Pandey
KLKanak Lata
Kanak Lata
JSJyoutishman Saikia
Jyoutishman Saikia
Background: This study aims to analyze risk factors, clinical profiles, treatment protocols, and disease outcomes in histologically proven resectable vulvar cancer (VC) patients according to tumor stage. This is a retrospective analysis of a prospectively collected database of 20 VC patients from May 2014 to June 2019.Results: The mean age of VC diagnosis was 55 years, with a range of 38–84 years. The incidence was four cases per year. The disease incidence was significantly more in post-menopausal (65%) and multiparous (90%) women. According to FIGO staging of vulvar cancer, stages I, II, and III were assigned to 6, 1, and 11 patients respectively. Two patients suffered from stage IVa vulvar melanoma. All patients had undergone surgical interventions. Patients treated with only nonsurgical (chemotherapy/radiotherapy/chemo-radiotherapy) treatment modalities were excluded from the study. Fifteen patients were treated with wide local excision (WLE), bilateral inguinofemoral dissection (B/L IFLND), and primary repair. Four and one patients were treated with radical vulvectomy (RV) and modified radical vulvectomy (MRV) [with or without B/L IFLND and PLND] respectively. Reconstruction with V-Y gracilis myocutaneous and local rotation advancement V-Y fasciocutaneous flaps were done in two patients. Therapeutic groin nodal dissection was performed in 19 patients except in one patient who was treated by palliative radical vulvectomy. In the final histopathology reports, tumor size varies from 0.5 to 6.5 cm (mean 3.35 cm) with the predominance of squamous cell carcinoma (18 out of 20 patients). Only 10 out of 18 eligible patients received adjuvant treatment. Poor patient compliance has been one of the major reasons for adjuvant treatment attrition rate. Systemic and loco-regional metastasis occurred in 3 patients each arm respectively. Poor follow up of patients is the key limitation of our study.Conclusion: Vulvar cancer incidence was significantly high in post-menopausal and multiparous women. The most important prognostic factors were tumor stage and lymph node status. Oncological resection should be equated with functional outcome. The multidisciplinary team approach should be sought for this rare gynecological malignancy.

22 August 2023 in European Journal of Surgical Oncology
Verified
Journal Article
Closed access
SDSvs Deo
Svs Deo
BBBabul Bansal
Babul Bansal
SBSandeep Bhoriwal
Sandeep Bhoriwal
CBChandrasekhar Bal
Chandrasekhar Bal
AMAshutosh Mishra
Ashutosh Mishra
STSanjay Thulkar
Sanjay Thulkar

13 April 2018 in World Journal of Surgery
Verified
Journal Article
Closed access
PDF file
MRMukur Dipi Ray
Mukur Dipi Ray
AJAshish Jakhetiya
Ashish Jakhetiya
SKSunil Kumar
Sunil Kumar
AMAshutosh Mishra
Ashutosh Mishra
SSSeema Singh
Seema Singh
NSNootan Kumar Shukla
Nootan Kumar Shukla

2 May 2019 in Indian Journal of Surgical Oncology
Verified
Journal Article
Closed access
PDF file
SDS V Suryanarayana Deo
S V Suryanarayana Deo
AMAshutosh Mishra
Ashutosh Mishra
NSN K Shukla
N K Shukla
BSB Sandeep
B Sandeep


30 May 2023 in Cancers
Verified
Journal Article
Open access
PDF file
DPDivya Pillai
Divya Pillai
JNJyoti Narayan
Jyoti Narayan
AGAleksandra Gentry-Maharaj
Aleksandra Gentry-Maharaj
SDSuryanarayana Deo
Suryanarayana Deo
DVDehannathparambil Kottarathil Vijaykumar
Dehannathparambil Kottarathil Vijaykumar
Usha MenonUsha Menon
Usha Menon
Background: Low awareness of BC and its associated risk factors causes delays in diagnosis and impacts survival. It is critical to communicate BC risk to patients in a format that they are easily able to understand. Our study aim was to develop easy-to-follow transmedia prototypes to communicate BC risk and evaluate user preferences, alongside exploring awareness of BC and its risk factors. Methods: Prototypes of transmedia tools for risk communication were developed with multidisciplinary input. A qualitative in-depth online interview study was undertaken using a pre-defined topic guide of BC patients (7), their relatives (6), the general public (6), and health professionals (6). Interviews were analyzed using a thematic approach. Findings: Most participants preferred pictographic representations (frequency format) of lifetime risk and risk factors and storytelling using short animations and comic strips (infographics) for communicating genetic risk and testing: “In a short time, they explained it very well, and I liked it”. Suggestions included minimizing technical terminology, decreasing the delivery speed, “two-way dialogue”, and using local “language for different locations”. There was low awareness of BC, with some understanding of age and hereditary risk factors but limited knowledge of reproductive factors. Interpretation: Our findings support use of multiple context-specific multimedia tools in communicating cancer risk in an easy-to-understand way. The preference for storytelling using animations and infographics is a novel finding and should be more widely explored.